SCHEMBL3848019

SCHEMBL3848019

O=[N+]([O-])c1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.47
MEN1 O00255 5/20 0.47
THRB P10828 1/20 0.47
AURKA O14965 3/20 0.42
PTGS2 P35354 3/20 0.41
MAPT P10636 4/20 0.40
PKM P14618 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HPGD P15428 3/20 0.39
LMNA P02545 2/20 0.39
CYP19A1 P11511 1/20 0.39
PPARG P37231 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL519563 0.83 KDM4E (0.36) KMT2AMEN1AURKAPTGS2MAPT
SCHEMBL4313628 0.81 ABCC8 (0.41) KMT2AMEN1THRBAURKAPTGS2
SCHEMBL3846098 0.80 GAA (0.39) KMT2AMEN1AURKAPTGS2NPSR1
SCHEMBL3848485 0.80 MEN1 (0.42) KMT2AMEN1THRBAURKAPTGS2
SCHEMBL3846787 0.80 POLB (0.39) KMT2AMEN1PTGS2MAPTSMN1; SMN2
SCHEMBL3852882 0.79 KIF11 (0.43) KMT2AMEN1MAPTMAPK1ALDH1A1
SCHEMBL3855504 0.78 RIPK1 (0.39) KMT2AMEN1THRBAURKAMAPT
SCHEMBL4717109 0.78 MAP2K4 (0.42) KMT2AMEN1MAPTSMN1; SMN2MAPK1
SCHEMBL3847767 0.77 KMT2A (0.41) KMT2AMEN1THRBAURKAPTGS2
SCHEMBL3850096 0.76 PTGS2 (0.39) KMT2AMEN1THRBPTGS2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed